Each patient received an intravenous injection of 20 millicurie technetium 99 m sestamibi in the arm contralateral to the breast with the abnormality. Five minutes after injection, a ten minute lateral image of the breast with the suspected lesion was taken in the prone position with a lead shield between the two breasts